孟鲁司特钠治疗小儿肺炎支原体感染的效果  

Effect of Montelukast Sodium on Mycoplasma Pneumoniae Infection in Children

作　　者：王苗[1] WANG Miao(Department of Pediatrics,Zibo Maternal and Child Health Hospital,Zibo Shandong 255000,China)

机构地区：[1]淄博市妇幼保健院儿科,山东淄博255000

出　　处：《中国卫生标准管理》2020年第13期77-79,共3页China Health Standard Management

摘　　要：目的研究孟鲁司特钠对于小儿肺炎支原体感染后慢性咳嗽患儿的作用与效果。方法选出本院接受并治疗的84例小儿肺炎支原体感染后慢性咳嗽病例,纳入的时间段最开始由2017年5月—2019年3月,把阿奇霉素干混悬剂的42例作为A组,把孟鲁司特钠的42例作为B组,观察比较其结果。结果在治疗后,B组患儿临床症状消退时间对比A组患儿更低,差异具有统计学意义(P<0.05);在治疗后,B组患儿治疗疗效对比A组患儿更高,差异具有统计学意义(P<0.05)。结论对于小儿肺炎支原体感染后慢性咳嗽患儿,孟鲁司特钠效果颇为显著。Objective To study the effects and effects of montelukast sodium on children with chronic cough after infection with Mycoplasma pneumoniae.Methods 84 cases of chronic cough after Mycoplasma pneumoniae infection in our hospital were selected.From May 2017 to March 2019,42 cases of azithromycin dry suspension were taken as group A,and 42 cases of montelukast sodium as group B.The results were compared.Results After treatment,the time for clinical symptoms to recede in group B was lower than that in group A,with a significant difference(P<0.05).After treatment,the efficacy of treatment in group B was higher than that in group A.There is a significant difference(P<0.05).Conclusion For children with chronic cough after Mycoplasma pneumoniae infection,montelukast sodium has a significant effect.

关 键 词：孟鲁司特钠 治疗 肺炎支原体感染 效果 慢性咳嗽 小儿 

分 类 号：R985[医药卫生—药品]